A Novel Neuromodulation Method for Childhood Migraine: Comparing Noninvasive Pulsed Radiofrequency Therapy With...

Area of Science:

• Neurology
• Pediatrics
• Pain Management

Background:

• Childhood migraine presents a significant challenge in pediatric healthcare.
• Evaluating novel, noninvasive treatment options is crucial for improving patient outcomes.

Purpose of the Study:

• To assess the efficacy and safety of noninvasive pulsed radiofrequency (NiPRF) therapy for pediatric migraine.
• To compare NiPRF outcomes against standard calcium channel blockers (CCBs).

Main Methods:

• A randomized controlled trial involving 60 pediatric migraine patients (7-18 years).
• Comparison between daily flunarizine (CCB group) and weekly transcutaneous NiPRF to the greater occipital nerve.
• Assessment of headache severity, frequency, and disability using diaries and the Pediatric Migraine Disability Assessment score.

Main Results:

• Both NiPRF and CCBs significantly reduced headache frequency and severity.
• At 3 months, CCBs showed a greater reduction in headache frequency and disability scores.
• NiPRF demonstrated a favorable safety profile with no significant side effects, unlike CCBs which caused transient liver enzyme elevation in two patients.

Conclusions:

• NiPRF is a safe and effective noninvasive treatment for childhood migraine with comparable short-term efficacy to CCBs.
• NiPRF presents a promising alternative therapy due to its minimal side effects.
• Further research is recommended to evaluate long-term efficacy and optimize NiPRF protocols.